Compare RFL & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RFL | FSEA |
|---|---|---|
| Founded | 2017 | 1890 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Savings Institutions |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.1M | 61.5M |
| IPO Year | 2017 | 2022 |
| Metric | RFL | FSEA |
|---|---|---|
| Price | $1.49 | $13.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 58.8K | 4.4K |
| Earning Date | 03-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.28 | ★ 94.76 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $917,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $1.12 | $10.13 |
| 52 Week High | $3.19 | $15.00 |
| Indicator | RFL | FSEA |
|---|---|---|
| Relative Strength Index (RSI) | 76.62 | 56.24 |
| Support Level | $1.41 | $11.44 |
| Resistance Level | $1.60 | $14.03 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 75.61 | 37.98 |
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.